American Journal of Cardiology

Cardiology

Nutraceuticals alone or with ezetimibe aid in dyslipidemia

(HealthDay)—For statin-intolerant patients with dyslipidemia with ischemic heart disease treated with percutaneous coronary intervention, nutraceuticals alone or in combination with ezetimibe improve the lipid profile, ...

Cardiology

Statin treatment linked to reduced risk of cataracts

(HealthDay)—Statin treatment is associated with reduced risk of incident cataract development, according to a study published in the Dec. 15 issue of The American Journal of Cardiology.

Cardiology

Cardiovascular trial sponsorship significantly impacts findings

(HealthDay)—Large clinical studies that are sponsored by industry are more likely to report favorable outcomes and less likely to report unfavorable outcomes than those sponsored by the National Institutes of Health (NIH), ...

Cardiology

Nonalcoholic fatty liver disease predicts MACE in STEMI

(HealthDay)—For patients without diabetes with ST-segment myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI), nonalcoholic fatty liver disease (FLD) independently predicts impaired ...

Cardiology

Hypertension-linked ER visits common and increasing

(HealthDay)—Hypertension-related emergency department visits are relatively common and increased from 2006 to 2012, according to a study published in the Dec. 1 issue of The American Journal of Cardiology.

Cardiology

Normal coronary angiogram at 65 predicts survival

(HealthDay)—Patients with normal or near-normal coronary angiogram (CA) results at age 65 years or older have significantly longer survival than the general population, according to a study published in the Nov. 15 issue ...

Cardiology

Exercise capacity, heart rate response predict CAD outcomes

(HealthDay)—Exercise capacity (EC) and heart rate responses to exercise are effective predictors of short-term outcome among patients with stable coronary artery disease (CAD), according to a study published in the Nov. ...

Cardiology

Ranolazine bests old school antianginal medications

(HealthDay)—Newer antianginal (AA) medications such as ranolazine show substantial outcome improvements in chronic stable angina pectoris (CSA) compared to traditional medications, according to a study published in the ...

page 10 from 24